nach oben

Current Diabetes Reports

Erschienen in:

01.02.2021 | Hospital Management of Diabetes (A Wallia and J Seley, Section Editors)

The Financial Impact of an Inpatient Diabetes Management Service

verfasst von: Waqas Zia Haque, Andrew Paul Demidowich, Aniket Sidhaye, Sherita Hill Golden, Mihail Zilbermint

Erschienen in: Current Diabetes Reports | Ausgabe 2/2021

Einloggen, um Zugang zu erhalten

Abstract

Context

Diabetes is a leading metabolic disorder with a substantial cost burden, especially in inpatient settings. The complexity of inpatient glycemic management has led to the emergence of inpatient diabetes management service (IDMS), a multidisciplinary team approach to glycemic management.

Objective

To review recent literature on the financial and clinical impact of IDMS in hospital settings.

Methods

We searched PubMed using a combination of controlled vocabulary and keyword terms to describe the concept of IDMS and combined the search terms with a comparative effectiveness filter for costs and cost analysis developed by the National Library of Medicine.

Findings

In addition to several improved clinical endpoints such as glycemic management outcomes, IDMS implementation is associated with hospital cost savings through decreased length of stay, preventing hospital readmissions, hypoglycemia reduction, and optimizing resource allocation. There are other downstream potential cost savings in long-term patient health outcomes and avoidance of litigation related to suboptimal glycemic management.

Conclusion

IDMS may play an important role in helping both academic and community hospitals to improve the quality of diabetes care and reduce costs. Clinicians and policymakers can utilize existing literature to build a compelling business case for IDMS to hospital administrations and state legislatures in the era of value-based healthcare.

American Diabetes Association. Statistics About Diabetes. 2018. https://www.diabetes.org/resources/statistics/statistics-about-diabetes. Accessed April 13 2020.

Corsino L, Dhatariya K, Umpierrez G. Endotext. 2017.

Association AD. Economic costs of diabetes in the U.S. in 2017. Diabetes Care. 2018;43(4). https://doi.org/10.2337/dci18-0007.

Corl D, Thompson R, Suhr L, Wisse B. Efficacy of diabetes nurse expert team program to improve nursing confidence and expertise in caring for hospitalized patients with diabetes mellitus. J Nurses Prof Dev. 2014;30(3):134–42. https://doi.org/10.1097/NND.0000000000000068.CrossRefPubMed

Levetan C, Passaro M, Jablonski K, Kass M, Ratner R. Unrecognized diabetes among hospitalized patients. Diabetes Care. 1998;21(2):246–9.CrossRefPubMed

Gaines MPR. Impact of hyperglycemia on 30-day readmission rates. Diabetes. 2018;67:Supplement 1. https://doi.org/10.2337/db18-1332-P.CrossRef

BusinessWire. At a cost of $10,405 per patient stay, hypoglycemia in the hospital cannot be ignored. Glytec. 2019. https://glytecsystems.com/news/at-a-cost-of-10-405-per-patient-stay-hypoglycemia-in-the-hospital-cannot-be-ignored/. Accessed April 26 2020.

Monarch Medical Technologies. Why Inpatient Glycemic Management Matters Monarch Medical Technologies. https://monarchmedtech.com/why-it-matters/. Accessed April 10 2020.

Drincic AT, Akkireddy P, Knezevich JT. Common models used for inpatient diabetes management. Curr Diab Rep. 2018;18(10). https://doi.org/10.1007/s11892-018-0972-x.

10.

American Diabetes Association. 15. Diabetes care in the hospital: standards of medical care in diabetes—2020. Diabetes Care. 2020;43:S193–202.CrossRef

11.

Schnipper JL, Barsky EE, Shaykevich S, Fitzmaurice G, Pendergrass ML. Inpatient management of diabetes and hyperglycemia among general medicine patients at a large teaching hospital. J Hosp Med. 2006;1(3):145–50. https://doi.org/10.1002/jhm.96.CrossRefPubMed

12.

Rogers S. Inpatient care coordination for patients with diabetes. Diabetes Spectr. 2008;21(4):272–5. https://doi.org/10.2337/diaspect.21.4.272.CrossRef

13.

Mandel S, Langan S, Mathioudakis N, et al. Retrospective study of inpatient diabetes management service, length of stay and 30-day readmission rate of patients with diabetes at a community hospital. J Community Hosp Intern Med Perspect. 2019;9(2):64–73.CrossRefPubMedPubMedCentral

14.

Sidhaye A, Mathioudakis N, Bashura H, Sarkar S, Zilbermint M, Golden S. Building a business case for inpatient diabetes management teams: lessons from our center. Endocr Pract. 2019;25(6):612–5. https://doi.org/10.4158/EP-2018-0471.CrossRefPubMed

15.

Newton CA, Young S. Financial implications of glycemic control: results of an inpatient diabetes management program. Endocr Pract. 2006;12(Suppl 3):43–8. https://doi.org/10.4158/EP.12.S3.43.CrossRefPubMed

16.

Apsey HA, Coan KE, Castro JC, Jameson KA, Schlinkert RT, Cook CB. Overcoming clinical inertia in the management of postoperative patients with diabetes. Endocr Pract. 2014;20(4):320–8. https://doi.org/10.4158/EP13366.OR.CrossRefPubMed

17.

Koproski J, Pretto Z, Poretsky L. Effects of an intervention by a diabetes team in hospitalized patients with diabetes. Diabetes Care. 1997;20:1553–5. https://doi.org/10.2337/diacare.20.10.1553.CrossRefPubMed

18.

Wexler DJ, Beauharnais CC, Regan S, Nathan DM, Cagliero E, Larkin ME. Impact of inpatient diabetes management, education, and improved discharge transition on glycemic control 12 months after discharge. Diabetes Res Clin Pract. 2012;98(2):249–56. https://doi.org/10.1016/j.diabres.2012.09.016.CrossRefPubMedPubMedCentral

19.

Mendez CE, Ata A, Rourke JM, Stain SC, Umpierrez G. Daily inpatient glycemic survey (dings): a process to remotely identify and assist in the management of hospitalized patients with diabetes and hyperglycemia. Endocr Pract. 2015;21(8):927–35. https://doi.org/10.4158/EP14577.OR.CrossRefPubMed

20.

Rushakoff R, Sullivan M, MacMaster H, Shah A, Rajkomar A, Glidden D, et al. Association between a virtual glucose management service and glycemic control in hospitalized adult patients: an observational study. Ann Intern Med. 2017;166:621–7.CrossRefPubMed

21.

Dungan KM, Binkley P, Nagaraja HN, Schuster D, Osei K. The effect of glycaemic control and glycaemic variability on mortality in patients hospitalized with congestive heart failure. Diabetes Metab Res Rev. 2011;27(1):85–93. https://doi.org/10.1002/dmrr.1155.CrossRefPubMedPubMedCentral

22.

Grey NJ, Perdrizet GA. Reduction of nosocomial infections in the surgical intensive-care unit by strict glycemic control. Endocr Pract. 2004;10(Suppl 2):46–52. https://doi.org/10.4158/EP.10.S2.46.CrossRefPubMed

23.

Golden SH, Peart-Vigilance C, Kao WH, Brancati FL. Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes. Diabetes Care. 1999;22(9):1408–14. https://doi.org/10.2337/diacare.22.9.1408.CrossRefPubMed

24.

Wallia A, Gupta S, Garcia C, Schmidt K, Oakes DJ, Aleppo G, et al. Examination of implementation of intravenous and subcutaneous insulin protocols and glycemic control in heart transplant patients. Endocr Pract. 2014;20(6):527–35. https://doi.org/10.4158/EP13354.OR.CrossRefPubMed

25.

Warrington L, Ayers P, Baldwin AM, Wallace V, Riche KD, Saulters R, et al. Implementation of a pharmacist-led, multidisciplinary diabetes management team. Am J Health Syst Pharm. 2012;69(14):1240–5. https://doi.org/10.2146/ajhp110297.CrossRefPubMed

26.

Kerr L, Kalowes P, Dyo M. Nurse practitioner–led project to achieve euglycemia in cardiac surgery patients. J Nurse Pract. 2017;13(3):e137–e41.CrossRef

27.

Klinkner G, Murray M. Clinical nurse specialists lead teams to impact glycemic control after cardiac surgery. Clin Nurse Spec. 2014;28(4):240–6. https://doi.org/10.1097/NUR.0000000000000056.CrossRefPubMed

28.

Bansal V, Mottalib A, Pawar T, Abbasakoor N, Chuang E, Chaudhry A, et al. Inpatient diabetes management by specialized diabetes team versus primary service team in non-critical care units: impact on 30-day readmission rate and hospital cost. BMJ Open Diabetes Res Care. 2018;5(6):e000460.CrossRef

29.

Simmons D, Hartnell S, Watts J, Ward C, Davenport K, Gunn E, et al. Effectiveness of a multidisciplinary team approach to the prevention of readmission for acute glycaemic events. Diabet Med. 2015;32(10):1361–7.CrossRefPubMed

30.

Levetan C, Salas J, Wilets I, Zumoff B. Impact of endocrine and diabetes team consultation on hospital length of stay for patients with diabetes. Am J Med. 1995;99(1):22–8.CrossRefPubMed

31.

Flanagan D, Moore E, Baker S, Wright D, Lynch P. Diabetes care in hospital--the impact of a dedicated inpatient care team. Diabet Med. 2008;25(2):147–51. https://doi.org/10.1111/j.1464-5491.2007.02326.x.CrossRefPubMed

32.

Sampson M, Crowle T, Dhatariya K, et al. Trends in bed occupancy for inpatients with diabetes before and after the introduction of a diabetes inpatient specialist nurse service. Diabet Med. 2006;23:1008–15.CrossRefPubMed

33.

Adigopula S, Feng Y, Babu V, Parperis K, Amoateng-Adjepong Y, Zarich S. Hyperglycemia is associated with increased length of stay and total cost in patients hospitalized for congestive heart failure. World J Cardiovasc Dis. 2013;3:245–9.CrossRef

34.

Garg R, Schuman B, Bader A, Hurwitz S, Turchin A, Underwood P, et al. Effect of preoperative diabetes management on glycemic control and clinical outcomes after elective surgery. Ann Surg. 2018;267(5):858–62. https://doi.org/10.1097/SLA.0000000000002323.CrossRefPubMed

35.

Carlos A, Estrada M, Young J, et al. Outcomes and perioperative hyperglycemia in patients with or without diabetes mellitus undergoing coronary artery bypass grafting. Ann Thorac Surg. 2011;75:1392–9.

36.

HealthCatalyst. Systematic improvement of diabetes care in the inpatient setting. Health Catalyst. 2017. https://www.healthcatalyst.com/wp-content/uploads/2016/02/Systematic-Improvement-of-Diabetes-Care-in-the-Inpatient-Setting.pdf. Accessed April 5 2020.

37.

Coto J, Yehle K, Foli K. Relationship between standardized glycemic protocols and healthcare cost. Clin Nurs Res. 2014;25(1). https://doi.org/10.1177/1054773814539003.

38.

Spanakis E, Singh L, Siddiqui T, et al. Association of glucose variability at the last day of hospitalization with 30-day readmission in adults with diabetes. BMJ Open Diabetes Res Care. 2020;8:e000990. https://doi.org/10.1136/bmjdrc-2019-000990.CrossRefPubMedPubMedCentral

39.

Puig J, Supervia A, Marquez MA, Flores J, Cano JF, Gutierrez J. Diabetes team consultation: impact on length of stay of diabetic patients admitted to a short-stay unit. Diabetes Res Clin Pract. 2007;78(2):211–6. https://doi.org/10.1016/j.diabres.2007.03.010.CrossRefPubMed

40.

Ostling S, Wyckoff J, Ciarkowski SL, Pai C-W, Choe HM, Bahl V, et al. The relationship between diabetes mellitus and 30-day readmission rates. Clin Diabetes Endocrinol. 2017;3(1):3.CrossRefPubMedPubMedCentral

41.

Parekh W, Streeton S, Baker-Knight J, Montagnoli R, Nicoziani P, Marchesini G. The economic burden of insulin-related hypoglycemia in adults with diabetes: an analysis from the perspective of the Italian healthcare system. Diabetes Ther. 2018;9(3):1037–47.CrossRefPubMedPubMedCentral

42.

Munoz M, Pronovost P, Dintzis J, Kemmerer T, Wang N, Chang Y, et al. Implementing and evaluating a multicomponent inpatient diabetes management program: putting research into practice. Jt Comm J Qual Patient Saf. 2012;38(5):195–206.PubMedPubMedCentral

43.

2008 Trial Lawyers Report. Hypoglycemic event lawsuit settles for $4 million. Lubin & Meyer PC. 2008. http://www.lubinandmeyer.com/cases/hypoglycemic_malpractice.html. Accessed May 1 2020.

44.

Drugwatch. Jury awards $140M after prescription error Leads to woman’s death. Drugwatch. 2012. https://www.drugwatch.com/news/2012/12/19/jury-awards-140-million-prescription-error-death/. Accessed May 5 2020.

45.

Lilley S, Levine G. Management of hospitalized patients with type 2 diabetes mellitus. Am Fam Physician. 1998;57(5):1079–88.PubMed

46.

Kim S. Burden of hospitalizations primarily due to uncontrolled diabetes. Diabetes Care. 2007;30(5):1281–2. https://doi.org/10.2337/dc06-2070.CrossRefPubMed

47.

Beck J, Logan K, Hamm R, Sproat S, Musser K, Everhart P, et al. Reimbursement for pediatric diabetes intensive case management: a model for chronic diseases? Pediatrics. 2004;113(1):e47–50. https://doi.org/10.1542/peds.113.1.e47.CrossRefPubMed

48.

Cheng S, Wang C, Ko Y. Costs and length of stay of hospitalizations due to diabetes-related complications. J Diabetes Res. 2019;2019:1–6. https://doi.org/10.1155/2019/2363292.CrossRef

49.

O’Grady N, Alexander M, Dellinger E, et al. Guidelines for the prevention of intravascular catheter-related infec- tions. Centers for Disease Control and Prevention. MMWR Recomm Rep. 2002;51(RR-10):1–29.PubMed

50.

Dimick J, Pelz R, Consunji R, Swoboda S, Hendrix C, Lipsett P. Increased resource use associated with catheter-related bloodstream infection in the surgical intensive care unit. Arch Surg. 2001;136:229–34.CrossRefPubMed

51.

Guan W, Ni Z, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708–20.CrossRefPubMed

52.

Murphy K. COVID-19 recession to increase uninsurance rates, test Medicaid. Healthpayer Intelligence 2020. https://healthpayerintelligence.com/news/covid-19-recession-to-increase-uninsurance-rates-test-medicaid. Accessed April 2 2020.

53.

Dreher M, Kersten A, Bickenbach J, Balfanz P, Hartmann B, Cornelissen C, et al. The characteristics of 50 hospitalized COVID-19 patients with and without ARDS. Dtsch Arztebl Int. 2020;117:271–8.PubMedPubMedCentral

54.

Goyal P, Choi J, Pinheiro L, et al. Clinical characteristics of Covid-19 in New York City. N Engl J Med. 2020;382:2372–4. https://doi.org/10.1056/NEJMc2010419.CrossRefPubMed

55.

Li B, Yang J, Zhao F, Zhi L, Wang X, Liu L, et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020;109:531–8.CrossRefPubMed

56.

Klonoff D, Umpierrez G. COVID-19 in patients with diabetes: risk factors that increase morbidity. Metabolism. 2020;108:154224. https://doi.org/10.1016/j.metabol.2020.154224.CrossRefPubMedPubMedCentral

57.

Shelton C, Demidowich AP, Zilbermint M. Inpatient diabetes management during the COVID-19 crisis: experiences from two community hospitals. J Diabetes Sci Technol. 0(0):1932296820930268. https://doi.org/10.1177/1932296820930268.

Titel: The Financial Impact of an Inpatient Diabetes Management Service
verfasst von: Waqas Zia Haque
Andrew Paul Demidowich
Aniket Sidhaye
Sherita Hill Golden
Mihail Zilbermint
Publikationsdatum: 01.02.2021
Verlag: Springer US
Erschienen in: Current Diabetes Reports / Ausgabe 2/2021
Print ISSN: 1534-4827
Elektronische ISSN: 1539-0829
DOI: https://doi.org/10.1007/s11892-020-01374-0

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren.

Aquatherapie bei Fibromyalgie wirksamer als Trockenübungen

03.05.2024 Fibromyalgiesyndrom Nachrichten

Bewegungs-, Dehnungs- und Entspannungsübungen im Wasser lindern die Beschwerden von Patientinnen mit Fibromyalgie besser als das Üben auf trockenem Land. Das geht aus einer spanisch-brasilianischen Vergleichsstudie hervor.

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Das Risiko für Vorhofflimmern in der Bevölkerung steigt

02.05.2024 Vorhofflimmern Nachrichten

Das Risiko, im Lauf des Lebens an Vorhofflimmern zu erkranken, ist in den vergangenen 20 Jahren gestiegen: Laut dänischen Zahlen wird es drei von zehn Personen treffen. Das hat Folgen weit über die Schlaganfallgefährdung hinaus.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen